Results 211 to 220 of about 5,039,430 (289)
Some of the next articles are maybe not open access.

Aminocaproic Acid-Reply

Archives of Ophthalmology, 1984
In Reply. —The Ophthalmology Journal Club's inquiries are answerable by perusal of our article, by review of the previous literature, and by analysis of some unpublished data. All patients admitted to the University of Illinois Eye and Ear Infirmary, Chicago, with traumatic hyphema were placed on the study protocol, while the hyphema was active, if ...
Marilyn D. Farber   +4 more
openaire   +2 more sources

Tranexamic acid or epsilon-aminocaproic acid in total joint arthroplasty? A randomized controlled trial.

The Bone & Joint Journal, 2019
AIMS Antifibrinolytic agents, including tranexamic acid (TXA) and epsilon-aminocaproic acid (EACA), have been shown to be safe and effective for decreasing perioperative blood loss and transfusion following total hip arthroplasty (THA) and total knee ...
Kendall E Bradley   +8 more
semanticscholar   +1 more source

Epsilon-Aminocaproic Acid (EACA)

Seminars in Thrombosis and Hemostasis, 2008
Epsilon-aminocaproic acid (EACA) is a synthetic inhibitor of the plasmin-plasminogen system. It is the only potent antifibrinolytic agent which is commercially available in the United States. Effective blood levels of the drug are readily obtainable with either oral or intravenous administration, with very high levels of the drug being found in the ...
James D. Griffin, Leonard Ellman
openaire   +3 more sources

First Comparative Study of the Effectiveness of the Use of Tranexamic Acid against ε-Aminocapróic Acid via the Oral Route for the Reduction of Postoperative Bleeding in TKA: A Clinical Trial

The journal of knee surgery, 2019
Total primary knee replacement results in significant postoperative bleeding. There are reports that 20 to 50% of the patients require a blood transfusion, which has been related to many complications, resulting in the search for strategies to reduce ...
R. Morales-Ávalos   +10 more
semanticscholar   +1 more source

Seizure After Infusion of Aminocaproic Acid

JAMA: The Journal of the American Medical Association, 1978
AMINOCAPROIC acid is a useful agent in the management of hemophilia, particularly following extensive dental manipulations. The drug is widely used, in large measure because toxic reactions, including gastrointenstinal disturbances, dizziness, tinnitus, malaise, headache, rash, and conjunctival and nasal suffusion, are mild and rarely encountered.
Hafiz R. Parray   +2 more
openaire   +3 more sources

Reversal of ε-Aminocaproic Acid-Induced Massive Thromboemboli Using Tissue Plasminogen Activator During Cardiac Surgery: A Case Report.

A&A practice, 2019
ε-Aminocaproic acid is routinely used in cardiac surgery to prevent excess bleeding. It is rarely associated with thrombotic events. This case report illustrates the formation of intracardiac thrombi leading to massive pulmonary embolism during a ...
Kevin M. Roy, G. Rajan
semanticscholar   +1 more source

Convulsions Induced by Aminocaproic Acid Infusion

DICP, 1989
Aminocaproic acid is a widely used antifibrinolytic agent. Serious adverse effects associated with its use are rare, but we report on a patient with liver disease and cirrhosis who experienced a grand mal seizure during the intravenous administration of aminocaproic acid.
Reuben Rabinovici   +3 more
openaire   +3 more sources

The synthesis of N‐(ϵ‐aminocaproy L‐) ϵ‐aminocaproic acid. „Di‐ϵ‐aminocaproic acid”︁.

Recueil des Travaux Chimiques des Pays-Bas, 1952
AbstractThe possibility of synthesizing ω‐peptides by condensation of a ω‐phthalimido acid chloride with a ω‐amino acid and subsequent treatment with hydrazine has been investigated.The synthesis of N‐(ϵ‐aminocaproyl‐) ϵ‐aminocaproic acid is described.
Want, G.M. van der, Staverman, A.J.
openaire   +3 more sources

Aminocaproic Acid Prophylaxis in Traumatic Hyphema

Ophthalmic Surgery, Lasers and Imaging Retina, 1990
ABSTRACT Oral aminocaproic acid has been shown to be effective in clot stabilization and in the reduction of secondary bleeding rates in cases of traumatic hyphema. In a retrospective study of 105 patients treated during a 1-year period, we found the incidence of rebleeding in patients with traumatic hyphema who received aminocaproic acid ...
Thomas W. Wilson   +2 more
openaire   +3 more sources

Rhabdomyolysis Induced by Epsilon-Aminocaproic Acid

Annals of Pharmacotherapy, 1997
OBJECTIVE: To report a case of rhabdomyolysis associated with epsilon-aminocaproic acid (epsilon-ACA). CASE SUMMARY: A 33-year-old female patient with chronic granulocytic leukemia was treated with epsilon-ACA for approximately 3.5 months for thrombocytopenic bleeding. The initial dosage was 4 g po q6h.
Morel Rubinger, Beverly D Seymour
openaire   +3 more sources

Home - About - Disclaimer - Privacy